Polymorphisms of interleukin-10 and its receptor and lung function in COPD

European Respiratory Journal

Volumn 29, Issue 6, 2007, Pages 1120-1126

  He, J Q ^a   Shumansky, K ^a   Zhang, X ^a   Connett, J E ^c   Anthonisen, N R ^b   Sandford, A J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Forced expiratory volume in one second; Genetic polymorphism; Interleukin 10; Interleukin 10 receptor ; Lung function

Indexed keywords

BRONCHODILATING AGENT; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; RECEPTOR SUBUNIT;

ADULT; ALLELE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENE INTERACTION; HUMAN; HYPOTHESIS; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATIENT SELECTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TH2 CELL;

ADULT; ALLELES; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR ALPHA SUBUNIT; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 34250158764     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00002907     Document Type: Article

References (33)

1. Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE. Genetic and environmental determinants of level of pulmonary function. Am J Epidemiol 1984; 120: 518-530.
2. Wilk JB, Djousse L, Arnett DK, et al. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol 2000; 19: 81-94.
3. Gottlieb DJ, Wilk JB, Hannon M, et al. Heritability of longitudinal change in lung function. The Framingham study. Am J Respir Crit Care Med 2001; 164: 1655-1659.
4. Joost O, Wilk JB, Cupples LA, et al. Genetic loci influencing lung function: a genome-wide scan in the Framingham Study. Am J Respir Crit Care Med 2002; 165: 795-799.
5. Wilk JB, DeStefano AL, Arnett DK, et al. A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Respir Crit Care Med 2003; 167: 1528-1533.
6. Silverman EK, Palmer LJ, Mosley JD, et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002; 70: 1229-1239.
7. Takanashi S, Hasegawa Y, Kanehira Y, et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 1999; 14: 309-314.
8. Kurreeman FA, Schonkeren JJ, Heijmans BT, Toes RE, Huizinga TW. Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level. Hum Mol Genet 2004; 13: 1755-1762.
9. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
10. Lyon H, Lange C, Lake S, et al. IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol 2004; 26: 155-165.
11. Burgess JL, Fierro MA, Lantz RC, et al. Longitudinal decline in lung function: evaluation of interleukin-10 genetic polymorphisms; in firefighters. J Occup Environ Med 2004; 46: 1013-1022.
12. Gasche C, Grundtner P, Zwirn P, et al. Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-α production. J Immunol 2003; 170: 5578-5582.
13. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
14. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anti-cholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
15. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Paré PD. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 2001; 163: 469-473.
16. He JQ, Connett J, Anthonisen N, Paré P, Sandford A. The effects of polymorphisms of GSTM1, T1 and P1 gene or their interaction with cigarette exposure on lung function. Am J Respir Crit Care Med 2003; 167: A744.
17. He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 2004; 170: 388-394.
18. He JQ Connett JE, Anthonisen NR, Sandford AJ. Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers. Am J Respir Cell Mol Biol 2003; 28: 379-385.
19. National Heart, Lung and Blood Institute. SeattleSNPs Variation Discovery Resource. http://pga.gs.washington. edu Date last accessed: October 2003.
20. Channing Laboratory. Innate Immunity in Heart, Lung and Blood Disease. Programs for Genomic Applications. http://innateimmunity.net/ Date last accessed October 2003.
21. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106-120.
22. Hornik K, ed. Frequently Asked Questions on R. R: a Language and Environment for Statistical Computing. Vienna, 2004. http://www.r-project.org/
23. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955; 11: 375-386.
24. Burkett K, McNeney B, Graham J. A note on inference of trait associations with SNP haplotypes and other attributes in generalized linear models. Hum Hered 2004; 57: 200-206.
25. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003; 19: 376-382.
26. Millstein J, Conti DV, Gilliland FD, Gauderman WJ. A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet 2006; 78: 15-27.
27. Silverman EK, Weiss ST, Drazen JM, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 2152-2158.
28. Giron-Gonzalez JA, Moral FJ, Elvira J, et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000; 143: 31-36.
29. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study. Genes Immun 2002; 3: 407-413.
30. Lio D, Scola L, Crivello A, et al. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 2002; 3: 30-33.
31. Padyukov L, Hytonen AM, Smolnikova M, et al. Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 2004; 31: 422-425.
32. Seifart C, Dempfle A, Plagens A, et al. TNF-α-, TNF-β-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 2005; 65: 93-100.
33. Tanaka G, Sandford AJ, Burkett K, et al. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 2007; 29: 34-41.